Immuneering Corporation · NASDAQ:IMRX
Zeskind Benjamin J. bought 2,400 Immuneering Corporation shares (Form 4)
Traded Jun 23, 2026 · Filed Jun 24, 2026
On Jun 23, 2026, Zeskind Benjamin J. (Director, PRESIDENT AND CEO) bought 2,400 Immuneering Corporation shares at US$4.56 for US$10,944, leaving 2,315,252 shares. Filed Jun 24, 2026 (Form 4).
- Bought
- 2,400 shares
- Price
- US$4.56
- Value
- US$10,944
- Holding after
- 2,315,252 shares
- Trading plan
- No
- Role
- Director, PRESIDENT AND CEO
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Jun 23, 2026 | Class A Common Stock | Buy | 2,400 | US$4.56 | 2,315,252 | Direct |
Source
Related
- Immuneering Corporation
- Zeskind Benjamin J.
- Immuneering Corporation shareholders
- Schedule 13G · BlackRock, Inc. · Jul 28, 2026
- Form 4 · Hall Brett Matthew · Jun 16, 2026
- Schedule 13G/A · Zeskind Benjamin J. · Jan 22, 2026
- Schedule 13G/A · Empery Asset Management, LP · Jan 15, 2026
- Schedule 13G · Empery Asset Management, LP · Oct 21, 2025